Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. D-sarmentose
2. Sarmentose [mi]
3. Sarmentose, D-
4. (+)-sarmentose
5. 2-deoxy-3-o-methyl-d-fucose
6. 90-56-2
7. D-xylo-hexose, 2,6-dideoxy-3-o-methyl-
8. (3s,4s,5r)-4,5-dihydroxy-3-methoxyhexanal
9. D-xylo-hexopyranose, 2,6-dideoxy-3-o-methyl-
10. 41f6sj1248
11. Unii-41f6sj1248
12. 13484-14-5
13. Schembl489623
14. Chebi:33982
15. Dtxsid30420111
16. Dtxsid201027449
17. 2,6-dideoxy-3-o-methyl-d-xylo-hexose
18. Q7424300
19. Wurcs=2.0/1,1,0/[od212m_3*oc]/1/
20. 530-01-8
| Molecular Weight | 162.18 g/mol |
|---|---|
| Molecular Formula | C7H14O4 |
| XLogP3 | -1.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 162.08920892 g/mol |
| Monoisotopic Mass | 162.08920892 g/mol |
| Topological Polar Surface Area | 66.8 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 115 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Sarmentose manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sarmentose, including repackagers and relabelers. The FDA regulates Sarmentose manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sarmentose API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sarmentose supplier is an individual or a company that provides Sarmentose active pharmaceutical ingredient (API) or Sarmentose finished formulations upon request. The Sarmentose suppliers may include Sarmentose API manufacturers, exporters, distributors and traders.
click here to find a list of Sarmentose suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Sarmentose Drug Master File in Japan (Sarmentose JDMF) empowers Sarmentose API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Sarmentose JDMF during the approval evaluation for pharmaceutical products. At the time of Sarmentose JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Sarmentose suppliers with JDMF on PharmaCompass.
Sarmentose Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sarmentose GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sarmentose GMP manufacturer or Sarmentose GMP API supplier for your needs.
A Sarmentose CoA (Certificate of Analysis) is a formal document that attests to Sarmentose's compliance with Sarmentose specifications and serves as a tool for batch-level quality control.
Sarmentose CoA mostly includes findings from lab analyses of a specific batch. For each Sarmentose CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sarmentose may be tested according to a variety of international standards, such as European Pharmacopoeia (Sarmentose EP), Sarmentose JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sarmentose USP).
LOOKING FOR A SUPPLIER?
